Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Fellow’s Forum Case Report: When Pulmonary Symptoms Point to Rheumatic Disease

Naina Rastalsky, MD  |  Issue: September 2013  |  September 1, 2013

His past medical history included hypertension, hyperlipidemia, gastroesophageal reflux disease, Ray­naud’s phenomenon for the past five years, a history of arthritis (the details of which were unclear), and chronic back pain. He had no family history of rheumatologic disease. His medications taken prior to admission were lovastatin, aspirin, lisinopril, and ranitidine. He had no known drug allergies. He lived with his girlfriend of 12 years and worked as a chef. He had never smoked. He had no significant travel history.

On exam he was intubated and sedated. He was febrile to 103.3º F. Blood pressure was 100/60 mmHg, heart rate 60 beats per minute while on pressors. Tidal volume was set to 400 ml, respiratory rate to 35, fraction of inspired oxygen (FiO2) to 1.0, with a positive end-expiratory pressure of 14. He had anasarca with a calculated fluid overload of 16 liters. His heart sounds were regular with no murmurs. He had coarse respiratory sounds on lung exam. There was no synovitis in any joints. Thickened cracked skin was noted on the palmar surface of the thumb, index, and middle fingers bilaterally (see Figure 1).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Laboratory workup showed a WBC of 23.8, with neutrophil predominance. Arterial blood gas showed a pH of 7.23, a pCO2 of 69 mmHg, pO2 of 337 mmHg on FiO2 of 1.0. Serum creatinine was 0.95 (ref 0.8–1.3 mg/dL). Urinalysis revealed no red blood cells or protein. Creatine kinase (CK) was 80 (normal range 60–400 U/L). Liver function tests were normal except for alanine transaminase 106. Blood cultures and cultures from BAL were negative, as was the polymerase chain reaction test for pneumocystis jiroveci. He had three negative stains for acid-fast bacilli (AFB) and a HIV test was negative. The urine specimens were negative for legionella and histoplasma antigens.

Chest CT at our hospital showed improvement in the lung consolidations but new lobular ground-glass opacities (see Figure 2). This was felt to be consistent with improving pneumonia and subsequent development of adult respiratory distress syndrome (ARDS). Steroids were held due to lack of significant improvement and concerns for worsening prognosis in late stage ARDS. All antibiotics were discontinued. An aggressive diuresis plan was initiated. Cytology from BAL returned cytopathic changes suspicious for herpes simplex virus (HSV). Acyclovir was initiated while it was unclear whether these changes represented contamination, reactivation, or active infection. His respiratory status did not improve.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Diffuse ground-glass opacities, posterior lobe predominant consolidations, and pneumomediastinum.
Figure 2A: Diffuse ground-glass opacities, posterior lobe predominant consolidations, and pneumomediastinum.

Diffuse ground-glass opacities, posterior lobe predominant consolidations, and pneumomediastinum.
Figure 2B: Diffuse ground-glass opacities, posterior lobe predominant consolidations, and pneumomediastinum.

Rheumatologic workup included a negative antineutrophil cytoplasmic antibody test, rheumatoid factor, cyclic citrullinated peptide antibody, cryoglobulin, antinuclear antibody (ANA), dsDNA, and Scl-70 and Jo-1 antibodies. He was noted to have a positive cytoplasmic antibody with a titer of 1:160. Ro antibody was positive at 129 (normal 0–19.99). Antibodies to other extractable nuclear antigens as well as cardiolipin antibodies, beta-2-glycoprotein antibodies, and the lupus anticoagulant were all negative.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsSystemic Sclerosis Tagged with:Antisynthetase SyndromearthralgiasPulmonaryrespiratoryRheumatic Disease

Related Articles

    New Tools for Myositis Diagnosis, Classification & Management

    April 15, 2019

    CHICAGO—At Hot Topics in Myositis, a session at the 2018 ACR/ARHP Annual Meeting, three experts discussed new classification criteria for idiopathic inflammatory myopathies (IIM) and offered practical primers on overlap myositis conditions and inclusion body myositis (IBM). New Myositis Classification Criteria After a 10-year development process, the new EULAR/ACR Classification Criteria for Adult and Juvenile…

    Fellow’s Forum Case Report: Diagnosing Antisynthetase Syndrome

    May 1, 2013

    A variable combination of interstitial lung disease, myopathy, fever, joint involvement, and mechanic’s hands characterize this systemic autoimmune syndrome

    Autoantibodies in Autoimmune Myopathy

    Autoantibodies in Autoimmune Myopathy

    September 18, 2017

    In recent years, scientists and clinicians have learned a great deal about autoantibodies occurring in idiopathic inflammatory myopathies (IIMs). These new discoveries have reshaped our understanding of distinct clinical pheno­types in IIMs. Scientists continue to learn more about how these auto­antibodies shape pathophysiology, diagnosis, disease monitoring, prognosis and optimum treatment. Moving forward, these autoantibodies will…

    How to Diagnose Antisynthetase Syndrome

    How to Diagnose Antisynthetase Syndrome

    March 17, 2017

    Antisynthetase syndrome (AS) is strongly associated with the presence of antibodies to aminoacyl-transfer RNA (tRNA) synthetases (ARSs) that are implicated in the pathogenesis of myositis and interstitial lung disease (ILD). Antibodies against eight antisynthetases have been identified and are detected in 16–26% of patients with idiopathic inflammatory myopathies (IIM).1 Serum assays for five of these…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences